Clinical and endoscopic aspects of metastases to the gastrointestinal tract

Abstract

Background Studies that describe metastases to the gastrointestinal (GI) tract are restricted to small case series. An increase in the frequency of this condition is expected, so it would be useful to better characterize the endoscopic aspects of metastasis to the GI tract. The aims of this study were to describe the frequency and endoscopic features of the lesions, and to analyze the survival rate after diagnosis of metastasis.

Methods This was a retrospective, single-center, observational study, conducted between 2009 and 2017. Patients with metastasis to the GI tract were included.

Results 95 patients were included. Melanoma (25.3 %), lung (15.8 %), and breast (14.7 %) were the most frequent primary tumors. The most common endoscopic presentation was a solitary, ulcerated lesion in the gastric body. Conventional biopsy was diagnostic in 98.9 % of the cases. The mean and median survival rates were 13.3 months (95 % confidence interval [CI] 8.2 – 18.3) and 4.7 months (95 %CI 3.7 – 5.6), respectively. Palliative treatment with chemo- and/or radiotherapy after the diagnosis of the metastasis was related to a higher survival rate.

Conclusions Melanoma, lung, and breast cancer were the most common primary tumors to metastasize to the GI tract. The endoscopic features could not predict the primary site of the tumor. The finding of metastasis in the GI tract is related to the final stage of the cancer disease but patients who received palliative treatment with chemo- and/or radiotherapy after diagnosis of GI metastasis had higher survival rates.

• References

• 1 Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin 2016; 66: 7-30
• 2 Alizadeh AM, Shiri S, Farsinejad S. Metastasis review: from bench to bedside. Tumour Biol 2014; 35: 8483-8523
• 3 Sleeman JP, Christofori G, Fodde R. et al. Concepts of metastasis in flux: the stromal progression model. Semin Cancer Biol 2012; 22: 174-186
• 4 Langley RR, Fidler IJ. The seed and soil hypothesis revisited – the role of tumor-stroma interactions in metastasis to different organs. Int J Cancer 2011; 128: 2527-2535
• 5 Valastyan S, Weinberg RA. Tumor metastasis: molecular insights and evolving paradigms. Cell 2011; 147: 275-292
• 6 Gilg MM, Gröchenig HP, Schlemmer A. et al. Secondary tumors of the GI tract: origin, histology, and endoscopic findings. Gastrointest Endosc 2018; 88: 151-158.e1
• 7 Kobayashi O, Murakami H, Yoshida T. et al. Clinical diagnosis of metastatic gastric tumors: clinicopathologic findings and prognosis of nine patients in a single cancer center. World J Surg 2004; 28: 548-551
• 8 De Palma GD, Masone S, Rega M. et al. Metastatic tumors to the stomach: clinical and endoscopic features. World J Gastroenterol 2006; 12: 7326-7328
• 9 Kim GH, Ahn JY, Jung HY. et al. Clinical and endoscopic features of metastatic tumors in the stomach. Gut Liver 2015; 9: 615-622
• 10 Madeya S, Borsch G, Greiner L. et al. How frequent is the diagnosis of GI metastasis in an endoscopic patient sample in general internal medicine clinics? Results of a questionnaire survey of 34 medical clinics. Leber Magen Darm 1993; 23: 77-80
• 11 Toreson W. Secondary carcinoma of the esophagus as a cause of dysphagia. Arch Pathol 1944; 38: 82-84
• 12 Mizobuchi S, Tachimori Y, Kato H. et al. Metastatic esophageal tumors from distant primary lesions: report of three esophagectomies and study of 1835 autopsy cases. Jpn J Clin Oncol 1997; 27: 410-414
• 13 Abrahms H, Spiro R, Goldstein N. Metastases in carcinoma: analysis of 1000 autopsied cases. Cancer 1950; 3: 74-85
• 14 Telerman A, Gerard B, Van den Heule B. et al. Gastrointestinal metastases from extra-abdominal tumors. Endoscopy 1985; 17: 99-101
• 15 Wei SC, Su WC, Chang MC. et al. Incidence, endoscopic morphology and distribution of metastatic lesions in the gastrointestinal tract. J Gastroenterol Hepatol 2007; 22: 827-831
• 16 Oda I, Kondo H, Yamao T. et al. Metastatic tumors to the stomach: analysis of 54 patients diagnosed at endoscopy and 347 autopsy cases. Endoscopy 2001; 33: 507-510
• 17 Moreto M. Diagnosis of esophagogastric tumors. Endoscopy 2003; 35: 36-42
• 18 Namikawa T, Hanazaki K. Clinicopathological features and treatment outcomes of metastatic tumors in the stomach. Surg Today 2014; 44: 1392-1399
• 19 Sandru A, Voinea S, Panaitescu E. et al. Survival rates of patients with metastatic malignant melanoma. J Med Life 2014; 7: 572-576
• 20 Petersen RP, Hanish SI, Haney JC. et al. Improved survival with pulmonary metastasectomy: an analysis of 1720 patients with pulmonary metastatic melanoma. J Thorac Cardiovasc Surg 2007; 133: 104-110
• 21 Ufen MP, Köhne CH. et al. Metastatic breast cancer: are we treating the same patients as in the past?. Ann Oncol 2013; 25: 95-100
• 22 Riihimäki M, Hemminki A, Fallah M. et al. Metastatic sites and survival in lung cancer. Lung Cancer 2014; 86: 78-84